ACON
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$2.35
+2.62%Year over year
Reported trailing growth
- Revenue
- +33.1%
- EBITDA
- -33.4%
- EBIT
- -53.4%
- EPS
- +99.7%
- Free cash flow
- -24.0%
- Operating cash flow
- -27.7%
Forward estimates
Based on analyst estimates
- Revenue
- +126.8%
- EBITDA
- -33.5%
- EPS
- +34.9%
Three-year CAGR
- Revenue
- +7.8%
- EBITDA
- -11.8%
- EBIT
- -27.9%
- Net income
- -3.4%
- EPS
- +99.8%
- Free cash flow
- -28.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026